Latest news
INDV|Indivior PLC|Price:38.850|Chg%:+0.180 - TradingKeyTradingKey · Sat, 08 Aug 2026 09:18:51 GMTIndivior PLC (INDV) Q3 2024 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Fri, 07 Aug 2026 17:56:40 GMTIndivior PLC (INDV) Q4 2024 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Fri, 07 Aug 2026 17:04:58 GMTHC Wainwright Predicts Indivior's Q3 Earnings (NASDAQ:INDV) - MarketBeatMarketBeat · Thu, 06 Aug 2026 12:12:24 GMTIndivior PLC (INDV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Thu, 06 Aug 2026 07:00:00 GMTSupernus and Indivior merge to create scaled, CNS-focused entity - Pharmaceutical TechnologyPharmaceutical Technology · Tue, 04 Aug 2026 17:27:55 GMT$1.8bn merger unites Supernus and Indivior in CNS therapeutics play - BioXconomyBioXconomy · Tue, 04 Aug 2026 16:38:23 GMTIndivior Pharmaceuticals, Inc. (INDV) Stock Analysis: Analyst Consensus Points to 36% Upside Potential - DirectorsTalk InterviewsDirectorsTalk Interviews · Tue, 04 Aug 2026 09:21:09 GMT